VCM
DGX icon

Viewpoint Capital Management’s Quest Diagnostics DGX Stock Holding History

Viewpoint Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$235K Hold
1,200
– – 0.11% 96
2025
Q4 		$208K Hold
1,200
– – 0.09% 101
2025
Q3 		$229K Hold
1,200
– – 0.1% 98
2025
Q2 		$216K Hold
1,200
– – 0.11% 98
2025
Q1 		$203K Buy
+1,200
New +$197K 0.11% 102
2022
Q1 		– Sell
-1,200
Closed -$208K – 116
2021
Q4 		$208K Buy
+1,200
New +$183K 0.15% 86

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Viewpoint Capital Management's DGX Position: Q1 2026 in Review

Viewpoint Capital Management held its Quest Diagnostics (DGX) position steady in Q1 2026 at 1,200 shares worth $235K. The position accounts for 0.11% of the portfolio, ranked #96.

Viewpoint Capital Management first reported a position in DGX in Q4 2021 and has held it in 6 quarters since. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Viewpoint Capital Management held 1,200 shares of Quest Diagnostics worth $235K as of Q1 2026.
  • Viewpoint Capital Management left its Quest Diagnostics share count unchanged in Q1 2026.
  • Quest Diagnostics made up 0.11% of Viewpoint Capital Management's portfolio in Q1 2026, its #96 holding.
  • Viewpoint Capital Management first reported a position in Quest Diagnostics in Q4 2021 and has held it in 6 quarters since.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Viewpoint Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.